Share this article
Share this article
ALHAMBRA, Calif., June 2, 2021 /PRNewswire/ Apollo Medical Holdings, Inc. ( ApolloMed, and together with its subsidiaries and affiliated entities, the Company ) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare company focused on value-based care, today announced that the Company has entered into a definitive agreement with Sun Clinical Laboratories ( Sun Labs ), under which ApolloMed will purchase controlling interests in Sun Labs for $4.0 million.
Sun Labs is a CLIA-certified full-service lab that operates 19 locations across the San Gabriel Valley in southern California. The combination will allow ApolloMed to fully incorporate Sun Labs, an existing partner, into its integrated value-based care delivery platform, leading to greater operational efficiencies for ApolloMed and more integrated care for ApolloMed s members. ApolloMed will have the opportunity to leverage its extensive network and business developmen
Review of rules involving cyclists on roads welcomed tnp.sg - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tnp.sg Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ALHAMBRA, Calif., March 10, 2021 /PRNewswire/ Apollo Medical Holdings, Inc. ( ApolloMed, and together with its subsidiaries and affiliated entities, the Company ) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2020.
Financial Highlights for the Fourth Quarter and Year Ended December 31, 2020:
Company exceeded all previously disclosed guidance metrics for full-year 2020 (revenue, net income, EBITDA, and adjusted EBITDA)
Total revenue of $687.2 million for the year ended December 31, 2020, up 23% from $560.6 million for the prior year
Net income of $122.3 million for the year ended December 31, 2020, from $17.7 million for the prior year
Share this article
Share this article
ALHAMBRA, Calif., March 2, 2021 /PRNewswire/ Apollo Medical Holdings, Inc. ( ApolloMed, and together with its subsidiaries and affiliated entities, the Company ) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, today announced the appointment of Jeremy R. Jackson, M.D., to the newly created role of Chief of Staff, effective March 10, 2021.
In his role as Chief of Staff, Dr. Jackson will work closely with the executive team and play a key role in special projects for ApolloMed s technology platform, business development, strategy and operations.
Dr. Jackson brings 10 years of healthcare industry experience in management consulting and as a practicing physician to ApolloMed. He previously served as a Project Leader in the Boston Consulting Group s healthcare practice and, from 2011 to 2018, was a resident physician in the Department of General Surgery at Brigham and Women s Hospital (Harvard Me
(PRNewsfoto/Apollo Medical Holdings, Inc.)
ALHAMBRA, Calif. and NEW YORK, Jan. 26, 2021 /PRNewswire/ Apollo Medical Holdings, Inc. ( ApolloMed ) (NASDAQ: AMEH), a leading physician-centric, technology-powered healthcare management company, and CAIPA MSO, LLC ( CAIPA MSO ), a management services organization based out of New York, today announced a strategic alliance and investment by ApolloMed in CAIPA MSO.
CAIPA MSO provides management, consulting, administrative, and other support services to professional healthcare service providers, including to Chinese American IPA d/b/a Coalition of Asian-American IPA ( CAIPA ), a leading independent practice association serving the greater New York City area. With over 1,000 private practice providers covering over 70 specialties, CAIPA s provider network provides medical services and care to approximately 500,000 patients. CAIPA is consistently one of the top performing provider networks in the region in quality and value-based financ